You are here

Use of the low-FODMAP diet in inflammatory bowel disease.

Use of the low-FODMAP diet in inflammatory bowel disease. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:40-42 Authors: Gibson PR Abstract Irritable bowel syndrome (IBS)-like symptoms are not uncommon in patients with quiescent inflammatory bowel disease (IBD). While gluten-free diet is applied by patients, there are no reported interventional studies. The low-FODMAP diet, on the other hand, has efficacy similar to that seen in patients with IBS in three unblinded or observational studies of IBD cohorts who had well-controlled inflammatory disease and in one small randomized cross-over study. FODMAP intake by…

Read More

Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease.

Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:27-31 Authors: Ankersen DV, Carlsen K, Marker D, Munkholm P, Burisch J Abstract Health-care systems around the world are facing increasing costs. Non-adherent, chronically ill patients are one such expense incurred by health-care providers. Web-based home-monitoring of patients-or eHealth-has been shown to increase adherence to medical therapy, facilitate contact between patients and health-care professionals, and reduce time to remission for patients with inflammatory bowel disease…

Read More

Evaluating clinical, dietary and psychological risk factors for relapse of ulcerative colitis in clinical, endoscopic and histological remission.

Evaluating clinical, dietary and psychological risk factors for relapse of ulcerative colitis in clinical, endoscopic and histological remission. J Gastroenterol Hepatol. 2017 Feb 21;: Authors: Dhingra R, Kedia S, Venigalla PM, Kumar S, Singh N, Bopanna S, Singla V, Choudhury BN, Verma P, Tiwari V, Datta Gupta S, Makharia G, Ahuja V Abstract BACKGROUND: The literature on possible factors that could trigger a relapse in patients with ulcerative colitis (UC) in clinical, endoscopic and histological remission on long term follow up is scarce. AIM: To determine the relapse rate in…

Read More

O-013 Dietary Emulsifiers Directly Impact the Human Gut Microbiota Increasing Its Pro-inflammatory Potential and Ability to Induce Intestinal Inflammation.

O-013 Dietary Emulsifiers Directly Impact the Human Gut Microbiota Increasing Its Pro-inflammatory Potential and Ability to Induce Intestinal Inflammation. Inflamm Bowel Dis. 2017 Feb;23 Suppl 1:S5 Authors: Chassaing B, Van de Wiele T, Gewirtz A Abstract BACKGROUND: The intestinal microbiota plays a central role in the development of many chronic inflammatory diseases including inflammatory bowel disease. Accordingly, we recently demonstrated that administration of substances that alter microbiota composition, including the dietary emulsifiers polysorbate 80 (P80) and carboxymethylcellulose (CMC), promotes such inflammatory disorders. However, because inflammation itself impacts microbiota composition, it…

Read More

High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients with Ulcerative Colitis in Remission During Treatment With Aminosalicylates.

High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients with Ulcerative Colitis in Remission During Treatment With Aminosalicylates. Clin Gastroenterol Hepatol. 2017 Jan 18;: Authors: Barnes EL, Nestor M, Onyewadume L, De Silva P, Korzenik JR, DREAM Investigators Abstract BACKGROUND & AIMS: Dietary factors may have a significant role in relapse of disease among patients with ulcerative colitis (UC). However, the relationship between diet and UC is inadequately understood. We analyzed data from the diet’s role in exacerbations of mesalamine maintenance study to determine whether dietary…

Read More

Diet to the Rescue: Cessation of Pharmacotherapy After Initiation of Exclusive Enteral Nutrition (EEN) Followed by Strict and Liberalized Specific Carbohydrate Diet (SCD) in Crohn’s Disease.

Diet to the Rescue: Cessation of Pharmacotherapy After Initiation of Exclusive Enteral Nutrition (EEN) Followed by Strict and Liberalized Specific Carbohydrate Diet (SCD) in Crohn’s Disease. Dig Dis Sci. 2017 Jan 13;: Authors: Nakayuenyongsuk W, Christofferson M, Nguyen K, Burgis J, Park KT PMID: 28084605 [PubMed – as supplied by publisher] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/28084605?dopt=Abstract

Read More

The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.

The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 Jan 10;: Authors: Lewis JD, Albenberg L, Lee D, Kratz M, Gottlieb K, Reinisch W Abstract Inflammatory bowel disease is believed to be caused by a combination of genetic and environmental stimuli such as our diet. Diets high in meat and fats and low in fruits and vegetables have been associated with new-onset inflammatory bowel disease. This has triggered interest in using dietary modification as a treatment. The 3 principle models of dietary intervention…

Read More

Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.

Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. J Clin Gastroenterol. 2016 Dec 27;: Authors: Suskind DL, Cohen SA, Brittnacher MJ, Wahbeh G, Lee D, Shaffer ML, Braly K, Hayden HS, Klein J, Gold B, Giefer M, Stallworth A, Miller SI Abstract GOAL: To determine the effect of the specific carbohydrate diet (SCD) on active inflammatory bowel disease (IBD). BACKGROUND: IBD is a chronic idiopathic inflammatory intestinal disorder associated with fecal dysbiosis. Diet is a potential therapeutic option for IBD based on the hypothesis that…

Read More

Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn’s Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.

Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn’s Disease in Remission: A Pilot Randomized Double-Blind Controlled Study. Dig Dis Sci. 2016 Dec 14; Authors: Narula N, Cooray M, Anglin R, Muqtadir Z, Narula A, Marshall JK Abstract AIM: To assess the tolerability and efficacy of high-dose vitamin D3 in patients with Crohn’s disease (CD). METHODS: This was a randomized, double-blind placebo-controlled trial of high-dose vitamin D3 at 10,000 IU daily (n = 18) compared to 1000 IU daily (n = 16) for 12 months in patients with CD in remission. The primary outcome was change…

Read More

IBD: In Food We Trust.

Related Articles IBD: In Food We Trust. J Crohns Colitis. 2016 Nov;10(11):1351-1361 Authors: Marion-Letellier R, Savoye G, Ghosh S Abstract BACKGROUND AND AIMS: Both science and patients associate diet with inflammatory bowel disease [IBD]. There is no doubt that links between IBD and diet are numerous, based on both epidemiological studies and experimental studies. However, scientific evidence to support dietary advice is currently lacking, and dietary counselling for IBD patients is often limited in clinical practice to the improvement of nutrient intake. This review aimed to focus on both patient’s…

Read More
<< Go Back